(Q34228087)

English

Anti-obesity drugs: a critical review of current therapies and future opportunities

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

Anti-obesity drugs: a critical review of current therapies and future opportunities (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

author name string

Clapham JC

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Arch JR

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Tadayyon M

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

89

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

81-121

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.40.1081

Identifiers

10.1016/S0163-7258(00)00105-4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34228087&oldid=2127804505"